pharmaphorum37m
FDA expands label for Roche's eye disease implant Susvimo
The new indication adds to the 2021 approval of Susvimo (ranibizumab) for 'wet' or neovascular age-related macular ...
Le Lézard41m
A New Era in Neuroscience-Informed Patient Care: Cutting Edge Health Partners with Limitless Guided Visualizations
Cutting Edge Health, led by Orlando A. Landrum, MD, MBA?recognized for advanced interventional neuroscience ...
The real reason ‘female Viagra’ isn’t approved in the UK – and what to try instead
Interest in female Viagra has spiked recently – and it's hardly a surprise. Many women struggle with low libidos for a ...
Le Lézard46m
Vistagen Receives U.S. Patent for AV-101 to Treat Neuropathic Pain
Vistagen , a clinical-stage biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological disorders, today announced ...
Ultragenyx reports positive data on gene therapy for rare disease
NOVATO, Calif. - Ultragenyx Pharmaceutical Inc. (NASDAQ: NASDAQ:RARE), a $4.08 billion market cap biotechnology company with 27% revenue growth in the past year, today unveiled new data indicating ...
Naturopathic Doctor News29m
Phytoestrogens and Hormonal Modulation
Discover the role of phytoestrogens, including soy, in menopause management and breast cancer prevention. Learn how these ...
News Medical on MSN44m
Innovative method sheds light on the proteins behind gut health
A new Weizmann Institute study identified all of the proteins in a stool sample – those from the microbiome, the human body and food – revealing the hidden secrets of the intestines and their impact o ...